이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

경골 절골술에서 Adaptos®Ortho 쐐기 뼈 이식 대체물을 평가하기 위한 임상 연구

2026년 9월 28일 업데이트: Biomendex Oy

경골 절골술에서 Adaptos® Ortho 쐐기형 뼈 이식 대체물을 평가하기 위한 임상 연구: 무작위, 통제, 부분 맹검, 다기관 시험.

The aim of this study is to obtain performance and safety data of the new investigational device, dual-part Adaptos®Ortho Wedge, for its intended use in orthopaedic surgery. The study intervention is medial open wedge high tibial osteotomy (OWHTO) with loadbearing plate fixation, where a bone graft substitute material Adaptos®Ortho Wedge is evaluated when used as a bone void filler. Investigational device is expected to support bone formation in osteotomy gap and to resorb in the body.

The comparator arms are treated with medial OWHTO with plate fixation, either without a bone graft (the bone defect is left empty, non-augmented osteotomy) or by using a comparator product (chronOS® Wedge, semi-circular) as a bone void filler.

연구 개요

상세 설명

The study aims to evaluate the clinical performance and safety of Adaptos®Ortho Wedge (Biomendex Oy) bone graft material, when used for filling the medial osteotomy gap of the knee during OWHTO surgery.

This is partially randomized, subject and outcome assessor-blinded, controlled, multi-center study. The total study duration for each patient is planned to be 12 months. In total 6 visits per patient are scheduled in this study.

The study has three arms, and patients of all study arms are treated with medial OWHTO surgery to treat unicompartmental medial misalignment of the knee. Participants in the experimental arm (Arm 1) receive the investigational device, the osteotomy gap is filled with Adaptos®Ortho Wedge bone graft substitute. Participants in the control arm (Arm 2) receive the OWHTO treatment, where the osteotomy gap is left empty (no bone graft). Participants in the comparator device arm (Arm 3) receive the OWHTO treatment, where the osteotomy gap is filled with chronOS® Wedge bone graft substitute. In all three groups the metallic fixation plate (TomoFix®) is used for load bearing and for stabilizing the defect. The study device chronOS® Wedge (DePuy Synthes) and TomoFix® (DePuy Synthes) are CE-marked. The products are used within the indication.

The subject will be followed for twelve months following OWHTO.The radiological bone regeneration in the bony defect will be assessed at 6-weeks and 3-, 6-, and 12-months post-surgery.

연구 유형

중재적

등록 (추정된)

87

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Helsinki, 핀란드
        • Meilahti Bridge Hospital, Helsinki University Hospital
      • Hämeenlinna, 핀란드
        • Kanta-Häme Central Hospital
      • Tampere, 핀란드
        • Pihlajalinna Kelloportti
      • Győr, 헝가리
        • Petz Aladár University Teaching Hospital
      • Szeged, 헝가리
        • University of Szeged Szent-Györgyi Albert Clinical Center
      • Székesfehérvár, 헝가리
        • Szent György University Teaching Hospital

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

25년 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

설명

Inclusion Criteria:

  • Subjects aged between 25 and 65 years at the time of enrolment.
  • Subjects that sign and date a written, informed consent form (ICF) prior to the initiations of any trial procedures, after the nature of the trial has been explained according to regulatory requirements.
  • Subjects who can comply with trial procedures and are available for the duration of the trial.
  • Accepts all treatment arms.
  • Subjects with varus malalignment of the knee, scheduled to have medial open-wedge high tibial osteotomy (OWHTO) but are otherwise in good health at the time of entry into the trial as determined by medical history, physical/clinical examination, and clinical judgement of the investigator.
  • Full knee range of motion (ROM) (at least 5-120 degrees).
  • Preoperatively planned osteotomy 5-13 degrees of the proximal tibia done based on the weight-bearing x-ray of the full leg in AP view using Miniaci Method.
  • Body Mass Index (BMI) ≤30

Exclusion Criteria:

  • Previous knee area osteotomy or lower limb arthroplasty of the investigational knee.
  • Presence of the following unfavourable conditions: osteoporosis, infectious/inflammatory joint disease, infections, or inflammation in the operation area, clinically relevant, not medically managed, severe acute or chronic medical illness, immune-compromised, metabolic/systemic bone disorder, untreated malignant myeloma, Burkitt's lymphoma, lateral osteoarthritis (Kellgren-Lawrence grade >1)
  • Smoking or use of other nicotine products
  • Inability to follow the procedures of the study, e.g. due to language problems, dementia, psychiatric disorder or behaviour etc. of the participant
  • Recent history of substance abuse (ie, recreational drugs, alcohol) that would preclude reliable assessment.
  • Women who are pregnant or breast feeding or planning to become pregnant during the study.
  • Any use of calcitonin, bisphosphonates or recombinant PTH 1-34, 1-84 or other PTH fragments/analogues 6 months prior to surgery or during the study (12 months po).
  • Enrolment of the investigator, his/her family members, employees, and other dependent persons.
  • Involved in study of another investigational product that may affect outcome.

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 치료
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 더블

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Adaptos®Ortho Wedge

Bone augmentation after Open Wedge High Tibial Osteotomy (OWHTO), with Adaptos®Ortho Wedge (Biomendex Oy, synthetic bone graft material) in combination with a load bearing TomoFix® Medial High Tibia Plate (DePuy Synthes).

After screening and enrollment, subjects will undergo medial knee open wedge high tibial osteotomy (OWHTO) with load bearing locking plate fixation. A synthetic bone graft will be used as a bone void filler in the osteotomy defect. Follow-up visits will be at 6 weeks, 3 months, 6 months, and 12 months.

가짜 비교기: No bone graft

OWHTO with unfilled bony defect of the osteotomy gap with a load bearing TomoFix® Medial High Tibia Plate (DePuy Synthes).

After screening and enrollment, subjects will undergo medial knee open wedge high tibial osteotomy (OWHTO) with load bearing locking plate fixation, without bone grafting. Follow-up visits will be at 6 weeks, 3 months, 6 months, and 12 months.

활성 비교기: chronOS® Wedge

Bone augmentation, after OWHTO, with chronOS® Wedge (DePuy Synthes, synthetic beta-TCP bone graft) in combination with a load bearing TomoFix® Medial High Tibia Plate (DePuy Synthes).

After screening and enrollment, subjects will undergo medial knee open wedge high tibial osteotomy (OWHTO) with load bearing locking plate fixation. A synthetic bone graft will be used as a bone void filler in the osteotomy defect. Follow-up visits will be at 6 weeks, 3 months, 6 months, and 12 months.

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Radiographic bone regeneration of the osteotomy defect, comparison between three treatment arms.
기간: Change from baseline to 12 months.

Radiographic bone regeneration assessments of the native x-ray of the standing anteroposterior (AP) radiographs of the knee, evaluated in the mediolaterally divided five zones of the osteotomized gap area (Brosset 2011), with rating of six bone remodeling phases (phases 0-5, with the score of 5 for the best outcome).The primary endpoint is the sum of the remodeling phase scores (0-5) in each of the five zones of the osteotomized gap area (range 0-25). Assessment longitudinally at 6-weeks and repeatedly at 3-, 6-, and 12-months post-surgery. Primary evaluation is done 12 months after surgery.

Change from baseline to 12 months.

기타 결과 측정

결과 측정
측정값 설명
기간
Bone union of the tibial posterior cortex
기간: Change from baseline to 12 months.

Bone union of the tibial posterior cortex is assessed on lateral radiographs. Assessed at 6 weeks, 3-, 6-, and 12- months post-operation.

Change from baseline to 12 months.
Questionnaire: KOOS (Knee Injury and Osteoarthritis Outcome Score)
기간: Change of KOOS score from baseline to 12 months.

Patient-reported outcome measure (PROM) relating to knee pain and function. KOOS is a 42-item questionnaire. KOOS consists of 5 subscales; Pain, other Symptoms, Function/activities in daily living (ADL), Function in sport and recreation (Sport/Rec) and knee related Quality of life (QOL). Standardized answer options are given (5 Likert boxes) and each question is assigned a score from 0 to 4. A normalized score (100 indicating no symptoms and 0 indicating extreme symptoms) is calculated for each subscale. Assessed at preoperative visit, and 6 weeks, 3-, 6-, and 12- months post-operation.

Change of KOOS score from baseline to 12 months.
Questionnaire: FJS (Forgotten Joint Score)
기간: Change from baseline to 12 months.

Patient-reported outcome measure (PROM) focusing on patients' awareness of a specific joint in everyday life. FJS is a 12-item questionnaire. When calculating the total score for the FJS, all responses are summed (never, 1 point; almost never, 2 points; seldom, 3 points; sometimes, 4 points; mostly, 5 points) and the raw score is linearly transformed to obtain a total score range of 0 to 100. Finally, the score is subtracted from 100 to change the direction of the final score in such a way that high scores indicate a high degree of "forgetting" the joint-i.e. a low degree of awareness. Assessed at preoperative visit, and 6 weeks, 3-, 6-, and 12- months post-operation.

Change from baseline to 12 months.
NRS Knee Pain Intensity score
기간: Change from baseline to 12 months.

Patient reported outcomes relating to pain. Pain intensity is rated on a numeric rating scale where zero indicated no pain at all, and 10 represented the worst possible pain. Assessed at preoperative visit, and 6 weeks, 3-, 6-, and 12- months post-operation.

Change from baseline to 12 months.
Questionnaire: overall satisfaction to the procedure
기간: Change from baseline to 12 months.

Procedure satisfaction questionnaire. The study subjects complete 5-point Likert scale satisfaction questionnaire. The response category for subjects is 1 (Very dissatisfied), 2 (Dissatisfied), 3 (Neither satisfied nor dissatisfied), 4 (Satisfied), and 5 (Very satisfied). Assessed at 6 weeks, and 3-, 6-, and 12- months post-operation.

Change from baseline to 12 months.
Bone union in the defect area
기간: The change from baseline to 12- months post-operation

Bone union assessed on AP radiographs (+/-) at 6 weeks, and 3-, 6-, and 12-months post-surgery.

The change from baseline to 12- months post-operation
Knee CT scan
기간: 6 months post-operation.

Clinical assessment of bone regeneration, as based on computed tomography (CT) images of the knee.

6 months post-operation.
Full loadbearing
기간: Up to 3 months post-operation.

The date (or follow-up week, +/- 1 week) when a patient is capable of full loadbearing, to abandon crutches conclusively. Outcome measure will be assessed up to 3 months visit.

Up to 3 months post-operation.
Mechanical axis Hip knee ankle angle
기간: The change from baseline to 12- months post-operation.

The HKA angle in degrees is measured.

The change from baseline to 12- months post-operation.
Mechanical axis weight-bearing line ratio
기간: The change from baseline to 12- months post-operation.

The WBL ratio in percentage is measured.

The change from baseline to 12- months post-operation.
Work disability days
기간: Up to 3 months post-operation.

The date when a patient returned to work after surgery is recorded (number of work disability days post-surgery). Outcome measure will be assessed up to 3 months visit.

Up to 3 months post-operation.

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

스폰서

수사관

  • 연구 책임자: Mikko Manninen, MD, PhD, Orton Oy

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2024년 4월 8일

기본 완료 (추정된)

2028년 12월 1일

연구 완료 (추정된)

2028년 12월 1일

연구 등록 날짜

최초 제출

2022년 8월 2일

QC 기준을 충족하는 최초 제출

2022년 10월 5일

처음 게시됨 (실제)

2022년 10월 7일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 10월 1일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 28일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

미국에서 제조되어 미국에서 수출되는 제품

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다